CN115444896A - 一种用于缓解疲劳的固体香薰沉香精油片及其制作方法 - Google Patents
一种用于缓解疲劳的固体香薰沉香精油片及其制作方法 Download PDFInfo
- Publication number
- CN115444896A CN115444896A CN202210996445.4A CN202210996445A CN115444896A CN 115444896 A CN115444896 A CN 115444896A CN 202210996445 A CN202210996445 A CN 202210996445A CN 115444896 A CN115444896 A CN 115444896A
- Authority
- CN
- China
- Prior art keywords
- parts
- essential oil
- agilawood
- extraction
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000341 volatile oil Substances 0.000 title claims abstract description 102
- 239000007787 solid Substances 0.000 title claims abstract description 25
- 238000000222 aromatherapy Methods 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 235000004433 Simmondsia californica Nutrition 0.000 claims abstract description 38
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract description 22
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 22
- 229940041616 menthol Drugs 0.000 claims abstract description 22
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 16
- 239000000284 extract Substances 0.000 claims abstract description 16
- 239000003921 oil Substances 0.000 claims abstract description 16
- 235000019198 oils Nutrition 0.000 claims abstract description 16
- 239000002245 particle Substances 0.000 claims abstract description 16
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 15
- 235000008434 ginseng Nutrition 0.000 claims abstract description 15
- 235000005976 Citrus sinensis Nutrition 0.000 claims abstract description 14
- 240000002319 Citrus sinensis Species 0.000 claims abstract description 14
- 239000001331 rosmarinus officinalis leaf Substances 0.000 claims abstract description 13
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 13
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 12
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229940116229 borneol Drugs 0.000 claims abstract description 12
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 12
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 12
- 230000001939 inductive effect Effects 0.000 claims abstract description 12
- 239000000049 pigment Substances 0.000 claims abstract description 12
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims abstract description 11
- 239000004721 Polyphenylene oxide Substances 0.000 claims abstract description 10
- 150000002191 fatty alcohols Chemical class 0.000 claims abstract description 10
- 239000000203 mixture Substances 0.000 claims abstract description 10
- 210000005036 nerve Anatomy 0.000 claims abstract description 10
- 229920000570 polyether Polymers 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 63
- 238000000605 extraction Methods 0.000 claims description 53
- 239000000243 solution Substances 0.000 claims description 45
- 241000221095 Simmondsia Species 0.000 claims description 37
- 239000000843 powder Substances 0.000 claims description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 238000003756 stirring Methods 0.000 claims description 16
- 241001533085 Aquilaria sinensis Species 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 238000005520 cutting process Methods 0.000 claims description 8
- 239000011521 glass Substances 0.000 claims description 8
- 239000004519 grease Substances 0.000 claims description 8
- 229910001220 stainless steel Inorganic materials 0.000 claims description 8
- 239000010935 stainless steel Substances 0.000 claims description 8
- 241000196324 Embryophyta Species 0.000 claims description 6
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 claims description 6
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 6
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 6
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 239000004744 fabric Substances 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000007710 freezing Methods 0.000 claims description 5
- 230000008014 freezing Effects 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 238000007873 sieving Methods 0.000 claims description 5
- 238000000859 sublimation Methods 0.000 claims description 5
- 230000008022 sublimation Effects 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 238000009777 vacuum freeze-drying Methods 0.000 claims description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 238000004458 analytical method Methods 0.000 claims description 4
- 125000003118 aryl group Chemical group 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 4
- 238000000874 microwave-assisted extraction Methods 0.000 claims description 4
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 claims description 4
- 239000004033 plastic Substances 0.000 claims description 4
- 239000000741 silica gel Substances 0.000 claims description 4
- 229910002027 silica gel Inorganic materials 0.000 claims description 4
- 239000012258 stirred mixture Substances 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims description 3
- 235000003097 Artemisia absinthium Nutrition 0.000 claims description 3
- 240000001851 Artemisia dracunculus Species 0.000 claims description 3
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims description 3
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 3
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 3
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 3
- 229960000271 arbutin Drugs 0.000 claims description 3
- 239000001138 artemisia absinthium Substances 0.000 claims description 3
- 229960001948 caffeine Drugs 0.000 claims description 3
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 3
- 235000017803 cinnamon Nutrition 0.000 claims description 3
- 239000002131 composite material Substances 0.000 claims description 3
- 239000013078 crystal Substances 0.000 claims description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 3
- 239000011707 mineral Substances 0.000 claims description 3
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 3
- 229940026510 theanine Drugs 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 2
- 241000208340 Araliaceae Species 0.000 claims 2
- 239000011859 microparticle Substances 0.000 claims 1
- 230000004007 neuromodulation Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 7
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 3
- 230000007613 environmental effect Effects 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 244000251953 Agaricus brunnescens Species 0.000 abstract 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 abstract 2
- 241000271309 Aquilaria crassna Species 0.000 abstract 2
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 244000044822 Simmondsia californica Species 0.000 abstract 1
- 240000005373 Panax quinquefolius Species 0.000 description 13
- 239000000126 substance Substances 0.000 description 5
- 235000005979 Citrus limon Nutrition 0.000 description 4
- 244000131522 Citrus pyriformis Species 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 235000006679 Mentha X verticillata Nutrition 0.000 description 3
- 235000002899 Mentha suaveolens Nutrition 0.000 description 3
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000013268 sustained release Methods 0.000 description 3
- 239000012730 sustained-release form Substances 0.000 description 3
- 241000132012 Atractylodes Species 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- UJNOLBSYLSYIBM-WISYIIOYSA-N [(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl] (2r)-2-hydroxypropanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)[C@@H](C)O UJNOLBSYLSYIBM-WISYIIOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 240000004510 Agastache rugosa Species 0.000 description 1
- 244000307697 Agrimonia eupatoria Species 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000735234 Ligustrum Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 235000010580 Psophocarpus tetragonolobus Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 244000061457 Solanum nigrum Species 0.000 description 1
- 235000002594 Solanum nigrum Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 241001534930 Thymelaeaceae Species 0.000 description 1
- 241000046198 Triteleia hyacinthina Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000001772 cananga odorata hook. f. and thomas. oil Substances 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 235000000125 common agrimony Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 238000007443 liposuction Methods 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
- A61K36/835—Aquilaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Anesthesiology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种用于缓解疲劳的固体香薰沉香精油片及其制作方法,属于精油片技术领域。由下述重量份的原料制备而成,荷荷巴提取物1.5‑3.5份、通窍成分5‑9份、薄荷醇0.5‑1.5份、薄荷醇乳酸酯0.3‑0.9份、安抚成分10‑20份、神经调控剂0.1‑0.5份、冰片0.1‑0.5份、迷迭香叶油25‑35份、色素0.05‑0.25份、甜橙精油140‑160份、脂肪醇聚醚‑70.5‑2.5份、缓释持香粒子0.1‑0.4份、人参籽油15‑25份、沉香精油1‑2份。一种用于缓解疲劳的固体香薰沉香精油片的制作方法,操作简单方便,无需用到价格高昂的器材,对操作环境无苛刻要求,易于操作实施,能够实现量产,便于推广,一种用于缓解疲劳的固体香薰沉香精油片使用见效快,纯天然,使用安全无副作用,便于随时随地使用,方便快捷,无环境要求,无使用限制。
Description
技术领域
本发明涉及一种用于缓解疲劳的固体香薰沉香精油片及其制作方法,属于精油片技术领域。
背景技术
沉香,是指瑞香科植物白木香受到自然或人工伤害后通过自我修复而产生特殊树脂的结香木块。沉香可入药,具有行气止痛,温中止呕,纳气平喘之功效。常用于胸腹胀闷疼痛,胃寒呕吐呃逆,肾虚气逆喘急。沉香也作为香料,以燃烧、涂抹或熏香等方式芳香扩香,具有安神、舒缓压力、抗菌消炎等功效。
沉香自然生成需要十几年甚至数十年,时间十分地长。同时沉香自然资源匮乏,野生沉香树几乎销声匿迹。
精油是指从香料植物或泌香动物中加工提取所得到的挥发性含香物质的总称。通常,精油是从植物的花、叶、根、种子、果实、树皮、树脂、木心等部位通过水蒸气蒸馏法、冷压榨法、脂吸法或溶剂萃取法提炼萃取的挥发性芳香物质。精油又分稀释的(复方精油)和未经稀释的(单方精油)比如丁香精油。精油的挥发性很强,一旦接触空气就会很快挥发,所以精油必须用可以密封的深色瓶子储存。
沉香精油是由珍贵的沉香经过蒸馏萃取后提炼而成的,是沉香的精华所在。沉香精油对人体有着多重功效,例如:改善气场、舒缓压力、安眠抗郁、调理身心和促进身体新陈代谢等。在泡脚的热水中滴入几滴沉香精油,可以达到活血经络的目的,还能达到去除脚气脚臭的效果。由于天然沉香的不可再生性,提炼后的沉香油就更显得稀有和珍贵。
公开号CN101990973A(申请号201010564460.9)的中国发明专利文献公开了一种提神茶,它由以下重量份的水和中药材制成:水4000、中药材205;其中所述中药材包括以下重量份的原料:白扁豆10,粉葛根30,制香附10,龙葵草 30,五味子10,提麦冬5,制女贞15,薄荷15,仙鹤草30,西洋参或太子参或生晒参30,以及白砂糖20。公开号CN101732458B(申请号201010104195.6)的中国发明专利文献公开了一种提神醒脑抗疲劳的复方精油及含有该精油的湿纸巾,该复方精油由以下重量份配比的原料制备而成:薄荷醇20-50份,依兰花油0.5-2份,薰衣草油15-25份,迷迭香叶油3-10份,甜橙油20-30份,桉叶油素15-25份,柠檬叶油20-40份,薄荷油0.1-0.2份,丁香油20-50份,留兰香油30-55份。公开号CN102793772B(申请号201210325526.8)的中国发明专利文献公开了一种具有提神醒脑功能的植物精油,由下列重量份数的原料制成:玫瑰挥发油4-8份,藿香挥发油5-10份,木香挥发油6-12份,薄荷挥发油3-9 份,紫苏挥发油2-10份。
但是目前,传统的提神方式包括饮用提神饮料如浓茶、咖啡及功能性饮料等,此类方式见效慢,且并非所有场合下均可以获得这类饮料。因此,研制出一款安全有效,携带方便,无地点和时间限制的用于缓解疲劳的固体香薰沉香精油片,具有重要的现实意义。
鉴于此,现急需一种用于缓解疲劳的固体香薰沉香精油片及其制作方法来解决上述问题。
发明内容
有鉴于此,本发明提供一种用于缓解疲劳的固体香薰沉香精油片及其制作方法,以解决上述背景技术中提出的问题。
为实现上述目的,本发明提供如下技术方案:
本发明提供一种用于缓解疲劳的固体香薰沉香精油片及其制作方法,由下述重量份的原料制备而成,荷荷巴提取物1.5-3.5份、通窍成分5-9份、薄荷醇 0.5-1.5份、薄荷醇乳酸酯0.3-0.9份、安抚成分10-20份、神经调控剂0.1-0.5 份、冰片0.1-0.5份、迷迭香叶油25-35份、色素0.05-0.25份、甜橙精油140-160 份、脂肪醇聚醚-70.5-2.5份、缓释持香粒子0.1-0.4份、人参籽油15-25份、沉香精油1-2份。
本发明中沉香精油的提取方法为,先砍伐白木香树,去掉白木,雕成沉香薄片;再将沉香薄片粉碎成40目筛的沉香粉;然后把沉香粉用正丁烷加到萃取釜,采用亚临界流体萃取技术直接提取沉香精油,其提取条件:提取时间为0.5~1 小时,解析温度60℃,提取温度50℃,提取压力为0.4~0.5MPa;随后把第一次提取沉香精油后的渣用95%乙醇加到萃取釜进行第二次萃取提取沉香精油,其提取条件:提取时间为0.5~1.5小时,解析温度60℃,提取温度50℃,提取压力为0.4~0.5MPa。
本发明中荷荷巴提取物的提取方法为:将荷荷巴种子粉碎过10-30目筛,得到荷荷巴粉末;将体积分数为60-70%乙醇水溶液用0.1-0.5mol/L的氢氧化钠水溶液调节pH至11-13;然后将荷荷巴粉末用pH为11-13、体积分数为60-70%乙醇水溶液按料液质量比为1:(10-30)进行微波提取5-20min,用200-400目滤布过滤,滤液在3000-5000转/分下离心10-20分钟,取上清液在真空度为 0.03-0.09MPa、温度为50-70℃下浓缩3-7小时,得到浓缩液,将浓缩液进行真空冷冻干燥即得,控制浓缩液高度为5-10mm,设定预冻温度为-30~-20℃,当样品温度降到设定温度后保持1-3小时,设定升华温度为5-15℃,解析温度为 30-40℃,真空度10-20pa,干燥时间为15-25小时。
本发明中通窍成分包括白芷精油、苍术精油和石菖蒲精油。
本发明中安抚成分包括肉桂精油和艾草精油。
本发明中神经调控剂包括熊果苷、茶氨酸和咖啡因。
本发明中缓释持香粒子包括冻干植物复合矿物晶体多孔微粒。
本发明中以下步骤,l)将水放入不锈钢或耐热玻璃容器中,把NaOH缓慢倒入,搅拌均匀至NaOH完全溶解,并冷却至40~50℃;2)向NaOH溶液中缓慢加入油脂,边加边搅拌,搅拌20~40分钟,至油脂和NaOH溶液完全混合均匀;3) 按比例称取荷荷巴提取物1.5-3.5份、通窍成分5-9份、薄荷醇0.5-1.5份、薄荷醇乳酸酯0.3-0.9份、安抚成分10-20份、神经调控剂0.1-0.5份、冰片0.1-0.5 份、迷迭香叶油25-35份、色素0.05-0.25份、甜橙精油140-160份、脂肪醇聚醚-70.5-2.5份、缓释持香粒子0.1-0.4份、人参籽油15-25份、沉香精油1-2 份加入不锈钢或耐热玻璃容器中,搅拌均匀;4)将搅拌均匀的混合物溶液倒入塑料或硅胶模具中静置24~48小时;5)待混合物溶液凝固后脱模,置于阴凉通风处4~8周后即可使用。
与现有技术相比,本发明的有益效果:
本发明提供一种用于缓解疲劳的固体香薰沉香精油片及其制作方法,本发明中通过添加荷荷巴提取物,具有改善皮肤状态,修复皮肤弹性,可舒缓郁闷情绪,提神效果显著,使用后对皮肤无任何副作用,独特的香味起到了很好的愉悦身心的作用,进一步升华了使用效果。
通过添加沉香精油,能够起到舒缓紧张情绪,使人身心愉悦,促进睡眠,达到养生的效果。
通过添加缓释持香粒子,能够提高精油的缓释效果,延长精油的持香时间。
本发明中,一种用于缓解疲劳的固体香薰沉香精油片的制作方法,操作简单方便,无需用到价格高昂的器材,对操作环境无苛刻要求,易于操作实施,能够实现量产,便于推广。
本发明中,一种用于缓解疲劳的固体香薰沉香精油片使用见效快,纯天然,使用安全无副作用,便于随时随地使用,方便快捷,无环境要求,无使用限制。
具体实施方式
实施例一
本发明提供一种用于缓解疲劳的固体香薰沉香精油片及其制作方法,由下述重量份的原料制备而成,荷荷巴提取物1.5-3.5份、通窍成分5-9份、薄荷醇 0.5-1.5份、薄荷醇乳酸酯0.3-0.9份、安抚成分10-20份、神经调控剂0.1-0.5 份、冰片0.1-0.5份、迷迭香叶油25-35份、色素0.05-0.25份、甜橙精油140-160 份、脂肪醇聚醚-70.5-2.5份、缓释持香粒子0.1-0.4份、人参籽油15-25份、沉香精油1-2份。
本发明中沉香精油的提取方法为,先砍伐白木香树,去掉白木,雕成沉香薄片;再将沉香薄片粉碎成40目筛的沉香粉;然后把沉香粉用正丁烷加到萃取釜,采用亚临界流体萃取技术直接提取沉香精油,其提取条件:提取时间为0.5~1 小时,解析温度60℃,提取温度50℃,提取压力为0.4~0.5MPa;随后把第一次提取沉香精油后的渣用95%乙醇加到萃取釜进行第二次萃取提取沉香精油,其提取条件:提取时间为0.5~1.5小时,解析温度60℃,提取温度50℃,提取压力为0.4~0.5MPa。
本发明中荷荷巴提取物的提取方法为:将荷荷巴种子粉碎过10-30目筛,得到荷荷巴粉末;将体积分数为60-70%乙醇水溶液用0.1-0.5mol/L的氢氧化钠水溶液调节pH至11-13;然后将荷荷巴粉末用pH为11-13、体积分数为60-70%乙醇水溶液按料液质量比为1:(10-30)进行微波提取5-20min,用200-400目滤布过滤,滤液在3000-5000转/分下离心10-20分钟,取上清液在真空度为 0.03-0.09MPa、温度为50-70℃下浓缩3-7小时,得到浓缩液,将浓缩液进行真空冷冻干燥即得,控制浓缩液高度为5-10mm,设定预冻温度为-30~-20℃,当样品温度降到设定温度后保持1-3小时,设定升华温度为5-15℃,解析温度为30-40℃,真空度10-20pa,干燥时间为15-25小时。
基于实施例1的一种用于缓解疲劳的固体香薰沉香精油片及其制作方法的原理是:实施例中薄荷醇乳酸酯,又称:乳酸孟酯,CAS号:59259-38-0。
实施例中冰片为山东佰仟化工有限公司提供的日化级冰片。
实施例中甜橙精油为吉水县天成香料油厂提供的甜橙精油,提取来源甜橙果皮。
实施例中迷迭香叶油为海南鑫禾生物工程有限公司提供的迷迭香精油,提取来源迷迭香叶片。
实施例中荷荷巴种子为四川省荷荷芭工业有限公司提供的荷荷巴种子。
实施例中人参籽油为吉林省通化市金恺威生物科技制品有限公司提供的人参籽油,提取来源人参籽。
实施例中色素为柠檬黄,柠檬黄为山东优索化工科技有限公司提供的柠檬黄,色素索引号:CI19140。
一种用于缓解疲劳的固体香薰沉香精油片的原料为:荷荷巴提取物1.5-3.5 份、通窍成分5-9份、薄荷醇0.5-1.5份、薄荷醇乳酸酯0.3-0.9份、安抚成分 10-20份、神经调控剂0.1-0.5份、冰片0.1-0.5份、迷迭香叶油25-35份、色素0.05-0.25份、甜橙精油140-160份、脂肪醇聚醚-70.5-2.5份、缓释持香粒子0.1-0.4份、人参籽油15-25份、沉香精油1-2份。
实施例二
基于实施例1,本实施例还包括:由下述重量份的原料制备而成,荷荷巴提取物1.5-3.5份、通窍成分5-9份、薄荷醇0.5-1.5份、薄荷醇乳酸酯0.3-0.9 份、安抚成分10-20份、神经调控剂0.1-0.5份、冰片0.1-0.5份、迷迭香叶油 25-35份、色素0.05-0.25份、甜橙精油140-160份、脂肪醇聚醚-70.5-2.5份、缓释持香粒子0.1-0.4份、人参籽油15-25份、沉香精油1-2份。
本发明中沉香精油的提取方法为,先砍伐白木香树,去掉白木,雕成沉香薄片;再将沉香薄片粉碎成40目筛的沉香粉;然后把沉香粉用正丁烷加到萃取釜,采用亚临界流体萃取技术直接提取沉香精油,其提取条件:提取时间为0.5~1 小时,解析温度60℃,提取温度50℃,提取压力为0.4~0.5MPa;随后把第一次提取沉香精油后的渣用95%乙醇加到萃取釜进行第二次萃取提取沉香精油,其提取条件:提取时间为0.5~1.5小时,解析温度60℃,提取温度50℃,提取压力为0.4~0.5MPa。
本发明中荷荷巴提取物的提取方法为:将荷荷巴种子粉碎过10-30目筛,得到荷荷巴粉末;将体积分数为60-70%乙醇水溶液用0.1-0.5mol/L的氢氧化钠水溶液调节pH至11-13;然后将荷荷巴粉末用pH为11-13、体积分数为60-70%乙醇水溶液按料液质量比为1:(10-30)进行微波提取5-20min,用200-400目滤布过滤,滤液在3000-5000转/分下离心10-20分钟,取上清液在真空度为 0.03-0.09MPa、温度为50-70℃下浓缩3-7小时,得到浓缩液,将浓缩液进行真空冷冻干燥即得,控制浓缩液高度为5-10mm,设定预冻温度为-30~-20℃,当样品温度降到设定温度后保持1-3小时,设定升华温度为5-15℃,解析温度为 30-40℃,真空度10-20pa,干燥时间为15-25小时。
本发明中通窍成分包括白芷精油、苍术精油和石菖蒲精油。
本发明中安抚成分包括肉桂精油和艾草精油。
本发明中神经调控剂包括熊果苷、茶氨酸和咖啡因。
本发明中缓释持香粒子包括冻干植物复合矿物晶体多孔微粒。
本发明中以下步骤,l)将水放入不锈钢或耐热玻璃容器中,把NaOH缓慢倒入,搅拌均匀至NaOH完全溶解,并冷却至40~50℃;2)向NaOH溶液中缓慢加入油脂,边加边搅拌,搅拌20~40分钟,至油脂和NaOH溶液完全混合均匀;3) 按比例称取荷荷巴提取物1.5-3.5份、通窍成分5-9份、薄荷醇0.5-1.5份、薄荷醇乳酸酯0.3-0.9份、安抚成分10-20份、神经调控剂0.1-0.5份、冰片0.1-0.5 份、迷迭香叶油25-35份、色素0.05-0.25份、甜橙精油140-160份、脂肪醇聚醚-70.5-2.5份、缓释持香粒子0.1-0.4份、人参籽油15-25份、沉香精油1-2 份加入不锈钢或耐热玻璃容器中,搅拌均匀;4)将搅拌均匀的混合物溶液倒入塑料或硅胶模具中静置24~48小时;5)待混合物溶液凝固后脱模,置于阴凉通风处4~8周后即可使用。
所述荷荷巴提取物的制备方法为:将荷荷巴种子粉碎过16目筛,得到荷荷巴粉末;将体积分数为65%乙醇水溶液用0.3mol/L的氢氧化钠水溶液调节pH 至12;然后将荷荷巴粉末用pH为12、体积分数为65%乙醇水溶液按料液质量比为1:20浸提24小时,用300目滤布过滤,滤液在5000转/分下离心15分钟,取上清液在真空度为0.06MPa、温度为60℃下浓缩5小时,得到浓缩液;将浓缩液进行真空冷冻干燥,控制浓缩液高度为6mm,设定预冻温度为-25℃,当样品温度降到设定温度后保持2小时,设定升华温度为10℃,解析温度为35℃,真空度15pa,干燥时间为20小时,得到荷荷巴提取物。
上述一种用于缓解疲劳的固体香薰沉香精油片的制作方法为:l)将水放入不锈钢或耐热玻璃容器中,把NaOH缓慢倒入,搅拌均匀至NaOH完全溶解,并冷却至40~50℃;2)向NaOH溶液中缓慢加入油脂,边加边搅拌,搅拌20~40分钟,至油脂和NaOH溶液完全混合均匀;3)按比例称取荷荷巴提取物1.5-3.5 份、通窍成分5-9份、薄荷醇0.5-1.5份、薄荷醇乳酸酯0.3-0.9份、安抚成分 10-20份、神经调控剂0.1-0.5份、冰片0.1-0.5份、迷迭香叶油25-35份、色素0.05-0.25份、甜橙精油140-160份、脂肪醇聚醚-70.5-2.5份、缓释持香粒子0.1-0.4份、人参籽油15-25份、沉香精油1-2份加入不锈钢或耐热玻璃容器中,搅拌均匀;4)将搅拌均匀的混合物溶液倒入塑料或硅胶模具中静置24~48 小时;5)待混合物溶液凝固后脱模,置于阴凉通风处4~8周后即可使用。
以上对本发明及其实施方式进行了描述,这种描述没有限制性,总而言之, 如果本领域的普通技术人员受其启示,在不脱离本发明创造宗旨的情况下,不经 创造性的设计出与该技术方案相似的结构方式及实施例,均应属于本发明的保护 范围。
Claims (8)
1.一种用于缓解疲劳的固体香薰沉香精油片,其特征在于,由下述重量份的原料制备而成,荷荷巴提取物1.5-3.5份、通窍成分5-9份、薄荷醇0.5-1.5份、薄荷醇乳酸酯0.3-0.9份、安抚成分10-20份、神经调控剂0.1-0.5份、冰片0.1-0.5份、迷迭香叶油25-35份、色素0.05-0.25份、甜橙精油140-160份、脂肪醇聚醚-70.5-2.5份、缓释持香粒子0.1-0.4份、人参籽油15-25份、沉香精油1-2份。
2.根据权利要求1所述的一种用于缓解疲劳的固体香薰沉香精油片,其特征在于,所述沉香精油的提取方法为,先砍伐白木香树,去掉白木,雕成沉香薄片;再将沉香薄片粉碎成40目筛的沉香粉;然后把沉香粉用正丁烷加到萃取釜,采用亚临界流体萃取技术直接提取沉香精油,其提取条件:提取时间为0.5~1小时,解析温度60℃,提取温度50℃,提取压力为0.4~0.5MPa;随后把第一次提取沉香精油后的渣用95%乙醇加到萃取釜进行第二次萃取提取沉香精油,其提取条件:提取时间为0.5~1.5小时,解析温度60℃,提取温度50℃,提取压力为0.4~0.5MPa。
3.根据权利要求1所述的一种用于缓解疲劳的固体香薰沉香精油片,其特征在于,所述荷荷巴提取物的提取方法为:将荷荷巴种子粉碎过10-30目筛,得到荷荷巴粉末;将体积分数为60-70%乙醇水溶液用0.1-0.5mol/L的氢氧化钠水溶液调节pH至11-13;然后将荷荷巴粉末用pH为11-13、体积分数为60-70%乙醇水溶液按料液质量比为1:(10-30)进行微波提取5-20min,用200-400目滤布过滤,滤液在3000-5000转/分下离心10-20分钟,取上清液在真空度为0.03-0.09MPa、温度为50-70℃下浓缩3-7小时,得到浓缩液,将浓缩液进行真空冷冻干燥即得,控制浓缩液高度为5-10mm,设定预冻温度为-30~-20℃,当样品温度降到设定温度后保持1-3小时,设定升华温度为5-15℃,解析温度为30-40℃,真空度10-20pa,干燥时间为15-25小时。
4.根据权利要求1所述的一种用于缓解疲劳的固体香薰沉香精油片,其特征在于,所述通窍成分包括白芷精油、苍术精油和石菖蒲精油。
5.根据权利要求1所述的一种用于缓解疲劳的固体香薰沉香精油片,其特征在于,所述安抚成分包括肉桂精油和艾草精油。
6.根据权利要求1所述的一种用于缓解疲劳的固体香薰沉香精油片,其特征在于,所述神经调控剂包括熊果苷、茶氨酸和咖啡因。
7.根据权利要求1所述的一种用于缓解疲劳的固体香薰沉香精油片,其特征在于,所述缓释持香粒子包括冻干植物复合矿物晶体多孔微粒。
8.根据权利要求1-7任一项所述的一种用于缓解疲劳的固体香薰沉香精油片的制作方法,其特征在于,包括以下步骤,
l)将水放入不锈钢或耐热玻璃容器中,把NaOH缓慢倒入,搅拌均匀至NaOH完全溶解,并冷却至40~50℃;
2)向NaOH溶液中缓慢加入油脂,边加边搅拌,搅拌20~40分钟,至油脂和NaOH溶液完全混合均匀;
3)按比例称取荷荷巴提取物1.5-3.5份、通窍成分5-9份、薄荷醇0.5-1.5份、薄荷醇乳酸酯0.3-0.9份、安抚成分10-20份、神经调控剂0.1-0.5份、冰片0.1-0.5份、迷迭香叶油25-35份、色素0.05-0.25份、甜橙精油140-160份、脂肪醇聚醚-70.5-2.5份、缓释持香粒子0.1-0.4份、人参籽油15-25份、沉香精油1-2份加入不锈钢或耐热玻璃容器中,搅拌均匀;
4)将搅拌均匀的混合物溶液倒入塑料或硅胶模具中静置24~48小时;
5)待混合物溶液凝固后脱模,置于阴凉通风处4~8周后即可使用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210996445.4A CN115444896A (zh) | 2022-08-19 | 2022-08-19 | 一种用于缓解疲劳的固体香薰沉香精油片及其制作方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210996445.4A CN115444896A (zh) | 2022-08-19 | 2022-08-19 | 一种用于缓解疲劳的固体香薰沉香精油片及其制作方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115444896A true CN115444896A (zh) | 2022-12-09 |
Family
ID=84297845
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210996445.4A Withdrawn CN115444896A (zh) | 2022-08-19 | 2022-08-19 | 一种用于缓解疲劳的固体香薰沉香精油片及其制作方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115444896A (zh) |
-
2022
- 2022-08-19 CN CN202210996445.4A patent/CN115444896A/zh not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107137376A (zh) | 一种黑果枸杞提取物微囊及由其制备的枸杞制剂 | |
CN104258193A (zh) | 一种治疗神经衰弱和预防老年痴呆症的药物组合物 | |
CN103301339A (zh) | 一种用于降脂降压的中草药复方 | |
CN114028514B (zh) | 一种具有改善记忆作用枸杞子药食两用组合物及其制备方法与应用 | |
CN103881881A (zh) | 酵素酶益寿酒 | |
CN1709368A (zh) | 温中和胃的中药制剂及其制备方法 | |
CN111109495A (zh) | 一种养生固体饮料制作方法 | |
CN103142916B (zh) | 一种预防和治疗老年性痴呆病的药物 | |
CN104873433A (zh) | 一种艾草护肤霜及其制备方法 | |
CN112451578A (zh) | 一种橘红枇杷片的制备方法 | |
CN115444896A (zh) | 一种用于缓解疲劳的固体香薰沉香精油片及其制作方法 | |
CN111184758B (zh) | 一种包括功劳木醇提取物和虫草素的组合物、制剂及其应用 | |
CN101301330A (zh) | 党参蜂花粉胶囊及其制备方法 | |
CN113476409A (zh) | 一种新型配方颗粒及其制备方法 | |
CN106333324A (zh) | 一种蕤仁复合精粉的加工方法 | |
CN105995711A (zh) | 一种滇橄榄复方制剂及其制备方法 | |
JP7150142B2 (ja) | 広カッ香顆粒剤の噴霧乾燥方法 | |
CN100488543C (zh) | 大蒜局部外用止痒涂剂 | |
CN111227213A (zh) | 一种具有调节血糖作用的蜂蜜 | |
CN111543526A (zh) | 桦褐孔菌虫草补肝益肾祛风保健茶 | |
CN104664195A (zh) | 一种增强免疫力糖浆及其制备方法 | |
CN104026268A (zh) | 一种补脑安神保健芝麻油及其制备方法 | |
CN109007123A (zh) | 一种解酒养肝的速溶茶饮品及其制备方法 | |
CN108096371A (zh) | 一种补锌口服液及其制备方法 | |
CN105754710A (zh) | 一种茶油的制备方法及茶油制品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20221209 |